Vestmark Advisory Solutions’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.76M Sell
5,234
-34
-0.6% -$19.1K 0.03% 575
2026
Q1
$2.96M Sell
5,268
-90
-2% -$57.7K 0.03% 489
2025
Q4
$3.62M Buy
5,358
+3,313
+162% +$2.26M 0.05% 385
2025
Q3
$1.31M Buy
2,045
+501
+32% +$304K 0.02% 483
2025
Q2
$828K Buy
+1,544
New +$738K 0.01% 527
2025
Q1
Sell
-487
Closed -$201K 647
2024
Q4
$201K Sell
487
-368
-43% -$161K 0.01% 560
2024
Q3
$432K Buy
855
+89
+12% +$43.2K 0.02% 396
2024
Q2
$373K Buy
766
+193
+34% +$96.9K 0.02% 438
2024
Q1
$309K Sell
573
-8
-1% -$4.37K 0.01% 441
2023
Q4
$322K Sell
581
-11
-2% -$5.16K 0.02% 400
2023
Q3
$259K Sell
592
-2,823
-83% -$1.41M 0.02% 359
2023
Q2
$1.72M Sell
3,415
-333
-9% -$160K 0.07% 341
2023
Q1
$1.87M Buy
3,748
+1,044
+39% +$500K 0.08% 312
2022
Q4
$1.1M Sell
2,704
-429
-14% -$167K 0.05% 386
2022
Q3
$1.02M Buy
3,133
+958
+44% +$352K 0.06% 378
2022
Q2
$763K Sell
2,175
-288
-12% -$117K 0.04% 437
2022
Q1
$1.35M Buy
2,463
+217
+10% +$114K 0.08% 303
2021
Q4
$1.48M Buy
2,246
+102
+5% +$64K 0.08% 293
2021
Q3
$1.33M Buy
2,144
+65
+3% +$43.7K 0.09% 287
2021
Q2
$1.31M Buy
2,079
+78
+4% +$43.1K 0.09% 275
2021
Q1
$979K Buy
2,001
+426
+27% +$213K 0.09% 291
2020
Q4
$787K Buy
1,575
+104
+7% +$46.5K 0.09% 278
2020
Q3
$578K Buy
1,471
+325
+28% +$120K 0.08% 295
2020
Q2
$378K Buy
1,146
+148
+15% +$42.9K 0.06% 357
2020
Q1
$242K Buy
+998
New +$260K 0.05% 416

Other funds holding IDXX

Vestmark Advisory Solutions's IDXX Position: Q2 2026 in Review

Vestmark Advisory Solutions reduced its Idexx Laboratories (IDXX) stake by 0.65% in Q2 2026, selling an estimated $19.1K and leaving 5,234 shares worth $2.76M. The position accounts for 0.03% of the portfolio, ranked #575.

Vestmark Advisory Solutions first reported a position in IDXX in Q1 2020 and has held it in 25 quarters since. The position peaked at $3.62M in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Vestmark Advisory Solutions held 5,234 shares of Idexx Laboratories worth $2.76M as of Q2 2026.
  • Vestmark Advisory Solutions sold 34 Idexx Laboratories shares in Q2 2026, an estimated $19.1K.
  • Idexx Laboratories made up 0.03% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #575 holding.
  • Vestmark Advisory Solutions first reported a position in Idexx Laboratories in Q1 2020 and has held it in 25 quarters since.
  • Vestmark Advisory Solutions's Idexx Laboratories position peaked at $3.62M in Q4 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.